SYM 2206 (a potent non-competitive AMPA receptor antagonist) elevates the threshold for maximal electroshock-induced seizures in mice

1. Behr J. et al.: Kindling enhances kainite receptor-mediated depression of GABAergic inhibition in rat granule cells. Eur. J. Neurosci., 16, 861, 2002.10.1046/j.1460-9568.2002.02152.xSearch in Google Scholar

2. Ghersi C. et al.: Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: study with receptor antagonists. Neurochem. Int., 42, 283, 2003.10.1016/S0197-0186(02)00129-8Search in Google Scholar

3. Glantz S.A., Slinker B.K.: editors (2001). Primer of applied regression and analysis of variance, second edition. McGraw-Hill Inc.: New York, NY.Search in Google Scholar

4. Krauss G.L.: Perampanel: a selective AMPA antagonist for treating seizures. Epilepsy Curr., 13, 269, 2013.10.5698/1535-7597-13.6.269385474124348124Search in Google Scholar

5. Litchfield J.T., Wilcoxon F.: A simplified method of evaluating doseeffect experiments. J. Pharmacol. Exp. Ther., 96, 99, 1949.Search in Google Scholar

6. Löscher W., Fassbender C.P., Nolting B.: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res., 8, 79, 1991.Search in Google Scholar

7. Löscher W., Wauquier A.: Use of animal models in developing guiding principles for polypharmacy in epilepsy. Epilepsy Res., Suppl. 11, 61, 1996.Search in Google Scholar

8. Łuszczki J.J., Antkiewicz-Michaluk L., Czuczwar S.J.: Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Eur. J. Pharmacol., 602, 298, 2009.Search in Google Scholar

9. Łuszczki J.J., Czuczwar S.J.: How significant is the difference between drug doses influencing the threshold for electroconvulsions? Pharmacol. Rep., 57, 782, 2005.Search in Google Scholar

10. Łuszczki J.J., Czuczwar S.J.: Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 529, 2007.Search in Google Scholar

11. Łuszczki J.J. et al.: Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Naunyn- Schmiedebergs Arch. Pharmacol., 373, 169, 2006.10.1007/s00210-006-0055-416604339Search in Google Scholar

12. Łuszczki J.J. et al.: Isobolographic and behavioral characterizations of interactions between vigabatrin and gabapentin in two experimental models of epilepsy. Eur. J. Pharmacol., 595, 13, 2008.10.1016/j.ejphar.2008.07.05118708046Search in Google Scholar

13. Łuszczki J.J. et al.: Stiripentol in a dose-dependent manner elevates the threshold for maximal electroshock-induced seizures in mice. J. Pre-Clin. Clin. Res., 1, 155, 2007.Search in Google Scholar

14. Pelletier J.C. et al.: Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor. J. Med. Chem., 39, 343, 1996.Search in Google Scholar

15. Rogawski M.A.: AMPA receptors as a molecular target in epilepsy therapy. Acta Neurol. Scand. Suppl., 197, 9, 2013.10.1111/ane.12099450664823480151Search in Google Scholar

16. Rogawski M.A., Donevan S.D.: AMPA receptors in epilepsy and as targets for antiepileptic drugs. Adv. Neurol., 79, 947, 1999.Search in Google Scholar

17. Swinyard E.A., Brown W.C., Goodman L.S.: Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther., 106, 319, 1952.Search in Google Scholar

18. Welch N.C. et al.: Traditional AMPA receptor antagonists partially block Na v1.6-mediated persistent current. Neuropharmacology, 55, 1165, 2008. 10.1016/j.neuropharm.2008.07.01518687344Search in Google Scholar